RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis Meeting Abstract
| Authors: | Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L.; Kurteva, G.; Kowalyszyn, R. D.; Karyakin, O.; Neron, Y. V.; Cosgriff, T. M.; Collins, L.; Brechenmacher, T.; Lin, J. C.; Morgan, L.; Motzer, R. |
| Abstract Title: | RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis |
| Meeting Title: | ESMO Asia 2015 Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 26 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2015 Dec 18-21 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2015-12-01 |
| Start Page: | ix72 |
| Language: | English |
| ACCESSION: | WOS:000367158700239 |
| PROVIDER: | Thomson Reuters Web of Science™ |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdv524.04 |
| Notes: | Meeting Abstract: 239O -- Source: Wos |
